Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia

Hum Vaccin Immunother. 2022 Nov 30;18(5):2078634. doi: 10.1080/21645515.2022.2078634. Epub 2022 Jun 1.

Abstract

This study aims to provide evidence of hesitancy in receiving the COVID-19 booster vaccine and associated factors in the vaccinated population that have completed a primary vaccination series. An anonymous web-based survey was disseminated to Malaysian adults aged ≥18 years via social media platforms. A total of 1010 responses were collected, of which 43.0% (95%CI 39.9-46.0) declared a definite willingness to receive a COVID-19 vaccine booster, 38.2% (95%CI 35.2-44.3) reported being somewhat willing and only 5.7% (95%CI 4.5-7.4) reported being definitely unwilling. Demographically younger participants, those of higher income, Chinese ethnicity and those from the central region reported significantly higher odds of a definite willingness to receive the COVID-19 vaccine booster compared to the reference group (somewhat willing/undecided/somewhat unwilling/definitely unwilling). Having no side effects with past COVID-19 vaccination was associated with a significantly higher odds of definite willingness (OR = 2.82, 95% CI 1.33-5.99). A lower (range 6-22) pandemic fatigue score (OR = 2.34, 95% CI 1.75-3.22) and higher (range 24-30) preventive practices score (OR = 2.45, 95% CI 1.80-3.34) were also associated with higher odds of definite willingness. Regarding attitudes toward COVID-19 booster vaccine, having fewer concerns about the side effects of booster vaccination and the uncertain long-term safety of multiple COVID-19 vaccinations were found to create greater odds of a definite willingness to receive the COVID-19 vaccine booster. Findings from this study provided insights into demographic characteristics and important behavioral and attitudinal factors associated with COVID-19 vaccine booster hesitancy.

Keywords: COVID-19 vaccine booster acceptance; Malaysia; pandemic fatigue; side effects; vaccine hesitancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Cross-Sectional Studies
  • Humans
  • Immunization, Secondary
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Intention
  • Malaysia
  • Patient Acceptance of Health Care
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Influenza Vaccines

Supplementary concepts

  • COVID-19 vaccine booster shot

Grants and funding

This work was supported by the Special Projects of the Central Government Guiding Local Science and Technology Development, China [No.2021L3018]. The funder was not involved in study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; nor in the decision to submit the manuscript for publication.